Stephen Judd, CEng, MICHemE, FIEI

Arcadis
Process SME - Biologics / Cell & Gene Therapy
Stephen Judd is a Chartered Chemical Engineer, Fellow of Engineers Ireland and is Secretary of the IChemE Biochemical Engineering Special Interest Group (BESIG). He is an experienced technical manager and principal process engineer with more than 15 years experience in process engineering and facility design, mainly in biotech projects, and is experienced in all project stages from feasibility study to commissioning and qualification. Stephen has worked with a wide range of clients to develop suitable designs for clinical trial phase operations through to commercial-scale facilities. He has extensive experience with facility design, process systems design and scale-up, and process technology selection for hard-piped and single-use systems. His focus area is Cell & Gene Therapy and his current role is the Process SME - Biologics / Cell & Gene Therapy for DPS Group’s European Operations. He has been an ISPE member since 2016.

Related Articles

Gene Editing and Facility Retrofits for CRISPR and Beyond
Features
Gene Editing and Facility Retrofits for CRISPR and Beyond

With the approval of the first gene edited therapeutic in 2023, production of gene edited therapies is accelerating, introducing tough decisions for manufacturing development. Gene editing therapy production is complex, often involving multi-modality manufacturing operations in one facility to produce a single therapeutic. This article considers whether retrofitting an aging monoclonal...